Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 35803286

Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2022 Aug
First author
Budde LE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2022 Aug;23(8):967-969. doi: 10.1016/S1470-2045(22)00385-0.
    note
    Source null
    related pmid
    35803285
    relationship
    Comment in

Authors and identifiers

  1. name
    Budde LE
    type
    Author
  2. name
    Sehn LH
    type
    Author
  3. name
    Matasar M
    type
    Author
  4. name
    Schuster SJ
    type
    Author
  5. name
    Assouline S
    type
    Author
  6. name
    Giri P
    type
    Author
  7. name
    Kuruvilla J
    type
    Author
  8. name
    Canales M
    type
    Author
  9. name
    Dietrich S
    type
    Author
  10. name
    Fay K
    type
    Author
  11. name
    Ku M
    type
    Author
  12. name
    Nastoupil L
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Budde LE
    type
    Author
  2. name
    Sehn LH
    type
    Author
  3. name
    Matasar M
    type
    Author
  4. name
    Schuster SJ
    type
    Author
  5. name
    Assouline S
    type
    Author
  6. name
    Giri P
    type
    Author
  7. name
    Kuruvilla J
    type
    Author
  8. name
    Canales M
    type
    Author
  9. name
    Dietrich S
    type
    Author
  10. name
    Fay K
    type
    Author
  11. name
    Ku M
    type
    Author
  12. name
    Nastoupil L
    type
    Author
bibliography ids
  1. nci-bib-c3ade0ae7d7fc5dd5b0f2f2e
book metadata
content sha256
59e5aa7b5701950e98bae77569a485c27abe5841f715ff4d2bd3c6b33b5e3d9c
document type
citation
dois
  1. 10.1016/S1470-2045(22)00335-7
electronic publication date
display
2022 Jul 5
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:35803286
immutable id
pubmed:35803286@59e5aa7b5701950e98bae77569a485c27abe5841f715ff4d2bd3c6b33b5e3d9c
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
8
name
The Lancet. Oncology
nlm unique id
100957246
pages
1055-1065
volume
23
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2022 Aug;23(8):967-969. doi: 10.1016/S1470-2045(22)00385-0.
    note
    Source null
    related pmid
    35803285
    relationship
    Comment in
outcomes validated
false
pmid
35803286
provenance
batch id
9d150d55960e0c12aada
provider
NCBI PubMed ESummary
record sha256
d352875228f61c8e13d17306d05c0fec0a56c8fee79f624f5951e71b7d771af1
response sha256
2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
retrieved at
2026-09-09T23:48:09.820498+00:00
publication date
display
2022 Aug
precision
month
year
2022
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/35803286/
title
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study.

Preserved source evidence · Independent clinical review pending · Not medical advice